๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

p53 mutations in lung cancers from non-smoking atomic-bomb survivors

โœ Scribed by Y Takeshima; WP Bennett; CE Land; CC Harris; Y Takeshima; K Inai; Y. Takeshima; T Seyama; M Akiyama; S Tokuoka; K Mabuchi


Book ID
118553260
Publisher
The Lancet
Year
1993
Tongue
English
Weight
245 KB
Volume
342
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Survival in operable non-small-cell lung
โœ Thanos Sioris; Kirsti Husgafvel-Pursiainen; Antti Karjalainen; Sisko Anttila; An ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 68 KB ๐Ÿ‘ 2 views

Validated markers are needed to identify operable lung cancer patients with poor prognosis. About one-half of nonsmall-cell lung cancers (NSCLCs) carry a mutation in the p53 tumor-suppressor gene. We examined 101 NSCLC patients for surgical stage, completeness of resection, tobacco smoking, asbestos

Analysis of p53 mutations in histologica
โœ Weimin Gao; Hussam H. Mady; Mona F. Melhem; Phouthone Keohavong ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 163 KB

## Abstract Our previous study showed a characteristic p53 mutational spectrum in lung tumors from lung cancer patients in the Western Pennsylvania region. To further understand the involvement of p53 mutations in lung tumor development, in this study we compared p53 mutational spectra and distribu